Kymera Therapeutics begins phase IIb dosing of oral KT-621 in eosinophilic asthma patients, targeting STAT6, with top-line BREADTH study data expected...

Kymera Therapeutics begins phase IIb dosing of oral KT-621 in eosinophilic asthma patients, targeting STAT6, with top-line BREADTH study data expected...

A study of patients in the United States, Colombia, Nigeria and India is first to compare long COVID-19 brain symptoms across continents. ......

A study of patients in the United States, Colombia, Nigeria and India is first to compare long COVID-19 brain symptoms across continents. ......

YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is the only dual-agent presbyopia-correcting eye drop intentionally...

In late January 2026, the latest escalation in U.S. trade rhetoric was not merely another episode in a familiar cycle of tensions. Rather, it...

DelveInsight's "Polymyalgia Rheumatica Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the...

When international students assess whether to study in Hungary or Germany, they aren’t just comparing numbers on a page; they’re evaluating the...

BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ON SEDAR+ TORONTO — Satellos...

The Key Pancreatic Cancer Companies in the market include - AstraZeneca, Merck Sharp & Dohme, Actuate Therapeutics, Dragonfly Therapeutics, Keymed B,...